Chemoinformaics analysis of (10E,12Z)-9-HYDROXY-10,12-OCTADECADIENOIC-ACID
Molecular Weight | 665.1 | nRot | 20 |
Heavy Atom Molecular Weight | 588.492 | nRig | 23 |
Exact Molecular Weight | 664.579 | nRing | 4 |
Solubility: LogS | -7.512 | nHRing | 0 |
Solubility: LogP | 11.344 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 124 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 48 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 76 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 45 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 128.232 |
nHD | 1 | BPOL | 78.8477 |
QED | 0.061 |
Synth | 4.837 |
Natural Product Likeliness | 2.153 |
NR-PPAR-gamma | 0.483 |
Lipinski | Rejected |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.037 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.886 |
MDCK | 0.0000126 |
BBB | 0.233 |
PPB | 1.00734 |
VDSS | 2.691 |
FU | 0.00786221 |
CYP1A2-inh | 0.016 |
CYP1A2-sub | 0.178 |
CYP2c19-inh | 0.068 |
CYP2c19-sub | 0.787 |
CYP2c9-inh | 0.043 |
CYP2c9-sub | 0.954 |
CYP2d6-inh | 0.007 |
CYP2d6-sub | 0.262 |
CYP3a4-inh | 0.354 |
CYP3a4-sub | 0.435 |
CL | 7.436 |
T12 | 0.004 |
hERG | 0.96 |
Ames | 0.008 |
ROA | 0.01 |
SkinSen | 0.978 |
Carcinogencity | 0.042 |
EI | 0.007 |
Respiratory | 0.919 |
NR-Aromatase | 0.412 |
Antiviral | Yes |
Prediction | 0.576771 |